# Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

> **NCT00305682** · PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 295 (actual)

## Conditions studied

- Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** total body irradiation
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00305682
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2019-12-12
- **Final completion:** 2019-12-12
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305682, "Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00305682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*